New Drug May Help Prolong Survival For Head And Neck Cancer Patients
Fri, 19 Jan 2007 04:00 AM EST
... Preliminary findings show adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer live longer, according to a study presented at the plenary session of the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society. ...

Not Signed In -


